After $5B raise, critic asks Isomorphic Labs: five years and $7B+ spent, where are the drugs?
PatrickKidger · x · 2026-11-18
Mathematician Patrick Kidger revisits his critique of Isomorphic Labs. The company just raised $5B, but five years after founding and $7B+ in total, despite promising to cure all diseases, it appears to have cured none. He credits Iso's AF4 model as genuinely better on hard problems and doesn't want to understate the technical achievement, but insists success in AI drug discovery is measured in drugs, not models. A pointed critique of the gap between AI-for-Science narratives, capital enthusiasm, and actual output.
More from Companies & People
- Garry Tan mocks WSJ report on Jensen Huang being a demanding boss — garrytan · 2026-11-18
- Dualizer (YC F26) uses agentic physics simulation to debottleneck manufacturing — ycombinator · 2026-11-18
- Engineering leader tore into a doc that made sense—just because it was AI-generated — annetgriffin · 2026-11-18
- AI raises the cost of weak cloud architecture, says resilience expert — DavidLinthicum · 2026-11-18
- Jensen Huang publicly thanks supporters, admits 'serious mistakes' at NVIDIA in rare statement — FuSheng_0306 · 2026-11-18
- Gradon (YC F26) launches as an AI foundation to power humanity's next 35 years of construction — ycombinator · 2026-11-18